Barbara Caldwell
Women's Health · Cleveland, OHNPI 1003898032
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,297 of the $1,697 with a category attached, or 76.4%. 32 manufacturers reported payments, led by AstraZeneca at 26.7% of the total. Reporting peaked in 2023 at $765 and has fallen 97.2% since, to $22 in 2025.
Across 61 payments — averaging $27.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$452
- Incyte Corporation$170
- Bristol Myers Squibb$123
- Exelixis Inc.$76
- Beigene USA, Inc.$63
- Eisai Inc.$55
- plus $758 from 26 others
What the payments were for
- Speaking & faculty fees$40024%
- Food & beverage$1,29776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $452 |
| Incyte Corporation | 3 | $170 |
| Bristol Myers Squibb | 6 | $123 |
| Exelixis Inc. | 3 | $76 |
| Beigene USA, Inc. | 4 | $63 |
| Eisai Inc. | 3 | $55 |
| Immunogen, Inc. | 2 | $53 |
| Johnson & Johnson | 3 | $51 |
| Boston Scientific | 3 | $42 |
| Servier Pharmaceuticals LLC | 2 | $35 |
| Seagen Inc. | 2 | $35 |
| Stryker | 1 | $34 |
| Merck | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Karyopharm Therapeutics Inc. | 1 | $33 |
| Amgen | 2 | $33 |
| Novartis | 2 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Davol Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Myovant Sciences Inc. | 1 | $21 |
| CTI Biopharma Corp. | 1 | $20 |
| Gilead | 1 | $19 |
| Pfizer | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,697 in reported general payments places this provider in the 85th percentile of 333 women's health providers in Ohio.
Other women's health in Cleveland
- Cindy FarinaCleveland$10K
- Angalesia RuckerCleveland$9K
- Sarah BrazofskyCleveland$4K
- Suzanne SurovecCleveland$2K
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
- Kathryn Lowry-CollinsLebanon$9K
- Vivian RuszkiewiczColumbus$6K
- Lauren ZugaWarren$6K
- Lisa LeeseOregon$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.